NUCLEA BIOTECHNOLOGIES

nuclea-biotechnologies-logo

Nuclea Biotechnologies, LLC is headquartered in Pittsfield, Massachusetts with additional operations in Worcester, Massachusetts. Nuclea has three lines of business, each of which is operated by a separate wholly-owned subsidiary: Nuclea Diagnostic Laboratories (“NDL”) which has developed and is commercializing eleven unique diagnostic tests for colon, breast, leukemia, lung and prostate cancer; Nuclea Biomarkers (“NBM”) which performs research leading to novel molecular ... oncology therapeutics and diagnostics for the pharmaceutical and biotechnology industries and performs services by analyzing and testing the efficacy and validating other indications of existing therapeutics utilizing a highly characterized and consented patient database; and Nuclea Biotherapeutics (“NBT”) which has developed several therapeutics now in animal trials.

#People #Website #More

NUCLEA BIOTECHNOLOGIES

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics

Founded:
2005-01-01

Address:
Pittsfield, Massachusetts, United States

Country:
United States

Website Url:
http://www.nucleabio.com

Total Employee:
51+

Status:
Active

Contact:
14134459930

Email Addresses:
[email protected]

Total Funding:
27.65 M USD

Technology used in webpage:
SPF Amazon IPv6 Google Amazon Ohio Region NameBright



Current Advisors List

gunnar-fremuth_image

Gunnar Fremuth Board Observer @ Nuclea Biotechnologies
Board_observer

richard-vietor_image

Richard Vietor Board of Directors @ Nuclea Biotechnologies
Board_member

Current Employees Featured

not_available_image

James Winkelman
James Winkelman Medical Director @ Nuclea Biotechnologies
Medical Director

not_available_image

Tim Carty
Tim Carty Vice President, Data Management @ Nuclea Biotechnologies
Vice President, Data Management

not_available_image

Deborah August
Deborah August Chief Pathologist and Medical Director @ Nuclea Biotechnologies
Chief Pathologist and Medical Director

patrick-j-muraca_image

Patrick J. Muraca
Patrick J. Muraca President and Chief Executive Officer, co-founder and Board Member @ Nuclea Biotechnologies
President and Chief Executive Officer, co-founder and Board Member

Founder


patrick-j-muraca_image

Patrick J. Muraca

Official Site Inspections

http://www.nucleabio.com

  • Host name: ec2-34-205-242-146.compute-1.amazonaws.com
  • IP address: 34.205.242.146
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Nuclea Biotechnologies"

Nuclea Biotechnologies - LinkedIn

Since our founding in 2005, Nuclea has been focused on the development of IVD and RUO diagnostic assays and kits for the early detection and monitoring of biomarkers in oncology and endocrinology.See details»

Nuclea Biotechnologies - Crunchbase Company Profile & Funding

Nuclea is a translational medicine company dedicated to the discovery of proprietary biomarkers and in vitro companion diagnostic assays. View contacts for Nuclea Biotechnologies to access …See details»

Nuclea Biotechnologies - PitchBook

Developer of clinical diagnostic tests designed to offer diagnostic developments in cancer, including colon, stomach, leukemia, lung and prostate cancer, as well …See details»

Nuclea Biotechnologies - Company Profile & Staff Directory

Since our founding in 2005, Nuclea has been focused on the development of IVD and RUO diagnostic assays and kits for the early detection and monitoring of biomarkers in oncology …See details»

Nuclea Biotechnologies Inc - Company Profile and News

Nuclea Biotechnologies, Inc. identifies and develops gene and protein biomarkers for oncology and inflammation. The Company offers an oncology therapeutic program, which includes small...See details»

Nuclea Biotechnologies, Inc. - Drug pipelines, Patents, Clinical …

Explore Nuclea Biotechnologies, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Drug:WX-554, WX-UK1.See details»

Nuclea Biotechnologies - EquityNet

Nuclea has three lines of business, each of which is operated by a separate wholly-owned subsidiary: Nuclea Diagnostic Laboratories (NDL) which has developed and is …See details»

Personalized Medicine, Nuclea Biotechnologies, Translational …

Www.nucleabio.com. Nuclea is a translational medicine company dedicated to the discovery of proprietary biomarkers and in vitro companion diagnostic assays based on corresponding …See details»

Nuclea Biotechnologies Online Presentations Channel

Due to the large amount of data required for analyzing gene expression characteristics, Nuclea Biotechnologies seeks to add new database organization options to its already sophisticated computing system, including strategically …See details»

Nuclea Biotechnologies - VentureRadar

Website: http://www.nucleabio.com. Nuclea Biotechnologies is a healthcare company dedicated to the development and commercialization of clinical diagnostic assays identifying gene and …See details»

Aelan Cell Technologies Names Mary Lopez, Ph.D. Of Nuclea

Dec 9, 2015 · Nuclea develops and commercializes unique diagnostic tests for breast, prostate and other cancers, as well as for diabetes and other chronic diseases leading to novel …See details»

Nuclea launches strategic partnership with Ae | EurekAlert!

Nuclea Biotechnologies Inc. announced today that it is partnering with Aelan Cell Technologies Inc. for the development, validation and commercialization of novel biomarker tests and …See details»

Nuclea Biotechnologies Launches Strategic Partnership With

Jun 30, 2015 · CAMBRIDGE, MA--(Marketwired - June 30, 2015) - Nuclea Biotechnologies Inc. announced today that it is partnering with Aelan Cell Technologies Inc. (San Francisco, …See details»

Aelan Cell Technologies Names Mary Lopez, Ph.D. of Nuclea ...

Dec 7, 2015 · Aelan Cell Technologies announced today the appointment of Mary Lopez, Ph.D. to its Scientific Advisory Board. Dr. Lopez will serve as an advisor to Aelan's Molecular …See details»

Nuclea Biotechnologies, Inc. (Nuclea Biotechnologies, Inc.) - 药物 …

Fatty acid synthase is a multi-enzyme protein that catalyzes fatty acid synthesis and is not a single enzyme but a whole enzymatic system composed of two identical 272 KDa …See details»

National Center for Biotechnology Information

Do you want to analyze three-dimensional structures and highlight important features like active site residues, point mutations, and binding partners? Check out NCBI’s “I see in 3D” (iCn3D) – …See details»

Regulation of genome organization and gene expression by …

Oct 18, 2017 · We then discuss the mechanoregulation of 3D nuclear organization and its dynamics, as well as how this is coupled to chromosome organization and gene expression.See details»

Home | The Nuclear Waste Management Organization (NWMO)

The Nuclear Waste Management Organization (NWMO) is responsible for designing and implementing Canada's plan for the safe, long-term management of used nuclear fuel.See details»

Nuclear organization - Wikipedia

Nuclear organization refers to the spatial organization and dynamics of chromatin within a cell nucleus during interphase. There are many different levels and scales of nuclear organisation. …See details»

RNA and dynamic nuclear organization | Science - AAAS

Sep 12, 2014 · To ensure proper cell-type–specific gene regulation, each cell must organize its DNA, RNA, and protein within the nucleus in ways that differ in each cell type.See details»